TIMER 2.0 study results showed that RAR-α is highly expressed in many malignancies including BC, HNSC, KIRC, LUSC, LUAD, LGG, SARC, THCA, and UCEC (Figure 1). This evidence concerns the gene RARA and breast cancer.